Skye Bioscience (SKYE) Preferred Dividend Payments (2017)
Skye Bioscience (SKYE) posted quarterly Preferred Dividend Payments of $333000.0 for Q4 2017, down 53.16% quarter-over-quarter from $711000.0 in Q1 2017.
Skye Bioscience (SKYE) Preferred Dividend Payments (2017) Analysis & Trends
Skye Bioscience (SKYE) has reported Preferred Dividend Payments for 1 consecutive years, with $333000.0 the latest figure, recorded in Q4 2017.
- In Q4 2017, Preferred Dividend Payments changed N/A year-over-year to $333000.0; the TTM figure through Dec 2017 stood at $1.0 million (changed N/A YoY), while the FY2017 annual figure was $1.0 million, up 221.23% from the prior year.
- Preferred Dividend Payments eased to $333000.0 in Q4 2017 per SKYE's latest filing, from $711000.0 in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $711000.0 in Q1 2017 and bottomed at $333000.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Skye Bioscience | 10.86 Mn | 10.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 333,000.00 |
| Mar 31, 2017 | 711,000.00 |